— Know what they know.
Not Investment Advice

DNDT OTC

DND Technologies, Inc.
1W: +1.5% 1M: -44.6% 3M: -1.4% YTD: +22.2% 1Y: +179.1% 3Y: +76.7% 5Y: +139.2%
$0.17
-0.21 (-55.95%)
 
OTC · Consumer Defensive · Beverages - Non-Alcoholic · Tech Score Sell · Power 52 · $540200 mcap · 2M float · 0.315% daily turnover · Short 53% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.5M
52W Range0.0571-1.752
Volume8,000
Avg Volume5,329
Beta-4.30
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid Hong
Employees107
SectorConsumer Defensive
IndustryBeverages - Non-Alcoholic
IPO Date2013-01-16
954 Lexington Avenue
New York City, NY 10021
US
800 341 8940
About DND Technologies, Inc.

Headquartered in New York City, DND Technologies, Inc. was established in 1997. Operating as a holding company, DND Technologies specializes in the production and sale of diverse specialty balms. Beyond balms, the company is a key manufacturer and distributor of pharmaceutical goods. Its portfolio includes Bioassaygen Gel, formulated to diminish wrinkles and promote natural skin regeneration. The Bioassaygen Cosmetic Mask serves aesthetic enhancement purposes. Additionally, DND offers Bioassaygen Bio-Skin, an innovative skin replacement bandage, and Bioassaygen Delivery Gel, designed to accelerate natural skin renewal. These products reach consumers and businesses through a multi-channel distribution strategy, encompassing wholesale, retail outlets, and e-commerce platforms.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
GIFFHORN LOWELL 150,000 $0.06 2003-08-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms